Delcath Systems, Inc.

DCTH Healthcare Medical Devices

Delcath Systems, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $85.2 million, up 129.1% from fiscal 2024. In the quarter to June 2026, revenue grew 20.6%, EPS fell 12.5% and free cash flow fell 24.5%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

14.08 0.73 −4.93%
Market cap
$513.9M
P/E
1,408×
Fwd P/E
−17.8×
Dividend yield
—
F-score
7/9
Altman Z
13.26
Beneish M
−2.73
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
ROE

+8 more TTM periods

1.94% 3.00% 0.58% 0.47%
Piotroski F-Score
8 7 6 5
ROA
1.54% 2.70% 0.53% 0.42%
ROIC
14.18% 2.04% (4.32%) (4.49%)
Return on Tangible Assets
1.04% 2.42% 0.50% 0.44%
Average Days of Receivables
63.05 50.29 57.14 60.98
Free Cash Flow per Share
0.33 0.59 0.53 0.49
Free Cash Flow
12.04 20.97 19.19 17.51
Other line items

Show all line items

Columns are period end dates